Renal Cancer - Results from #5160

A rapid and systemic complete response to stereotactic body radiation therapy and pembrolizumab in a patient with metastatic renal cell carcinoma July 5, 2017

Surgical and Minimally Invasive Therapies for the Management of the Small Renal Mass July 5, 2017

The Feasibility and Safety of Surgery in Patients Receiving Immune Checkpoint Inhibitors: A Retrospective Study July 5, 2017

Radiation and PD-1 inhibition: Favorable outcomes after brain-directed radiation July 4, 2017

Identification of clear cell renal cell carcinoma and oncocytoma using a three-gene promoter methylation panel July 4, 2017

Resistance training as supportive measure in advanced cancer patients undergoing TKI therapy-a controlled feasibility trial July 3, 2017

Dose individualization of sunitinib in metastatic renal cell cancer: toxicity-adjusted dose or therapeutic drug monitoring July 3, 2017

LncRNA-SARCC suppresses renal cell carcinoma (RCC) progression via altering the androgen receptor(AR)/miRNA-143-3p signals June 30, 2017

Potential Susceptibility Loci Identified for Renal Cell Carcinoma by Targeting Obesity-related Genes June 30, 2017

Preoperative C-Reactive Protein Values as a Potential Component in Outcome Prediction Models of Metastasized Renal Cell Carcinoma Patients Receiving Cytoreductive Nephrectomy June 30, 2017

A Pilot Study of Stereotactic Body Radiation Therapy Combined with Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma June 30, 2017

Large-scale genome-wide screening of circulating microRNAs in clear cell renal cell carcinoma reveals specific signatures in late-stage disease June 29, 2017

Cabozantinib for the treatment of kidney cancer June 29, 2017

Radiotherapy for renal cell carcinoma: renaissance of an overlooked approach June 29, 2017

Preoperative Measurement of the Modified Glasgow Prognostic Score Predicts Patient Survival in Non-Metastatic Renal Cell Carcinoma Prior to Nephrectomy June 28, 2017

Intratumorally injected pro-inflammatory allogeneic dendritic cells as immune enhancers: a first-in-human study in unfavourable risk patients with metastatic renal cell carcinoma June 28, 2017

Biomarker-Based Phase II Trial of Savolitinib in Patients With Advanced Papillary Renal Cell Cancer June 27, 2017

Contemporary treatment of renal tumors: a questionnaire survey in the Nordic countries (the NORENCA-I study) June 27, 2017

Systematic Review of Immune Checkpoint Inhibition in Urological Cancers June 26, 2017

Proton Pump Inhibitors and Survival Outcomes in Patients With Metastatic Renal Cell Carcinoma June 26, 2017

Page 259 of 459